Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells

The ability to engineer primary human B cells to differentiate into long-lived plasma cells and secrete a de novo protein may allow the creation of novel plasma cell therapies for protein deficiency diseases and other clinical applications. We initially developed methods for efficient genome editing...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, King L., Meitlis, Iana, Hale, Malika, Chen, Chun-Yu, Singh, Swati, Jackson, Shaun W., Miao, Carol H., Khan, Iram F., Rawlings, David J., James, Richard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835153/
https://www.ncbi.nlm.nih.gov/pubmed/29273498
http://dx.doi.org/10.1016/j.ymthe.2017.11.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835153/
https://www.ncbi.nlm.nih.gov/pubmed/29273498
http://dx.doi.org/10.1016/j.ymthe.2017.11.012

Ejemplares similares